New trends in molecular and cellular biomarker discovery for colorectal cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New trends in molecular and cellular biomarker discovery for colorectal cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 25, Pages 5678
Publisher
Baishideng Publishing Group Inc.
Online
2016-07-04
DOI
10.3748/wjg.v22.i25.5678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Personalized treatment for patients with colorectal cancer: role of biomarkers
- (2015) Michael J Duffy Biomarkers in Medicine
- Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)
- (2015) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
- (2015) R. Yaeger et al. CLINICAL CANCER RESEARCH
- Effect of Genetic Deletion or Pharmacological Antagonism of Tumor Necrosis Factor Alpha on Colitis-associated Carcinogenesis in Mice
- (2015) Brian Craven et al. INFLAMMATORY BOWEL DISEASES
- Differential MIR-21 Expression in Plasma From Mesenteric Versus Peripheral Veins
- (2015) Mariano Monzo et al. MEDICINE
- Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb
- (2015) Wenhui Ma et al. Oncotarget
- Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives
- (2015) Amaninder Dhaliwal et al. World Journal of Gastrointestinal Oncology
- Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
- (2015) Lisa Perilli et al. Oncotarget
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- Biological significance of the CpG island methylator phenotype
- (2014) Hiromu Suzuki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis
- (2014) Bo Zhou et al. CANCER CAUSES & CONTROL
- Telomere Shortening: A Biological Marker of Sporadic Colorectal Cancer with Normal Expression of p53 and Mismatch Repair Proteins
- (2014) Mahdi Montazer Haghighi et al. Genetic Testing and Molecular Biomarkers
- Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis
- (2014) N. Whiffin et al. HUMAN MOLECULAR GENETICS
- A Stool DNA Test (Cologuard) for Colorectal Cancer Screening
- (2014) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Prospective Study of Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) and Risk of Colorectal Cancer
- (2014) Raaj S. Mehta et al. JNCI-Journal of the National Cancer Institute
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer
- (2014) J Gao et al. ONCOGENE
- Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
- (2014) Fabio Coppedè WORLD JOURNAL OF GASTROENTEROLOGY
- Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis
- (2014) Yue Li et al. Scientific Reports
- Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?
- (2014) Frank Berger et al. Theranostics
- Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value
- (2013) Hui Liu et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
- (2013) Eva Budinska et al. JOURNAL OF PATHOLOGY
- MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells
- (2013) Weiyun Wu et al. Molecular Cancer
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
- (2013) Felipe De Sousa E Melo et al. NATURE MEDICINE
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer
- (2013) Guang-Hui Liu et al. TUMOR BIOLOGY
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Methylation signature of lymph node metastases in breast cancer patients
- (2012) Zeinab Barekati et al. BMC CANCER
- Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
- (2012) Piro Lito et al. CANCER CELL
- Circulating MicroRNAs
- (2012) Esther E. Creemers et al. CIRCULATION RESEARCH
- Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer
- (2012) Ranit Aharonov INTERNATIONAL JOURNAL OF ONCOLOGY
- Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)
- (2012) Paulo M. Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer
- (2012) Nathaniel S Rial et al. Expert Review of Gastroenterology & Hepatology
- Mechanisms of telomere loss and their consequences for chromosome instability
- (2012) Keiko Muraki et al. Frontiers in Oncology
- Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
- (2011) C. Bokemeyer et al. ANNALS OF ONCOLOGY
- Molecular Predictors of Response to Antiangiogenesis Therapies
- (2011) Armin Gerger et al. CANCER JOURNAL
- miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer
- (2011) Yanlei Ma et al. GUT
- SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission
- (2011) Moshe S. Kim et al. JOURNAL OF CELL BIOLOGY
- Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
- (2011) Timothy S Maughan et al. LANCET
- Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer
- (2011) Ramin Radpour et al. PLoS One
- Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation Treatment
- (2011) Ramin Radpour et al. PLoS One
- Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
- (2010) Benoit Lefebure et al. ANNALS OF SURGERY
- Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
- (2010) Zeinab Barekati et al. HUMAN MOLECULAR GENETICS
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer
- (2010) Ramin Radpour et al. MODERN PATHOLOGY
- Efficient in vivo microRNA targeting of liver metastasis
- (2010) C Huynh et al. ONCOGENE
- Detection and Monitoring of Cell-Free DNA in Blood of Patients with Colorectal Cancer
- (2009) Heidi Schwarzenbach et al. Annals of the New York Academy of Sciences
- New Trends in Molecular Biomarker Discovery for Breast Cancer
- (2009) Ramin Radpour et al. Genetic Testing and Molecular Biomarkers
- Identifying Lynch syndrome
- (2009) Albert de la Chapelle et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer
- (2009) Mahdi Montazer Haghighi et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array
- (2009) R Radpour et al. ONCOGENE
- Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions
- (2008) C. M. Raynaud et al. ANNALS OF ONCOLOGY
- Vascular Endothelial Growth Factor Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth
- (2008) J. M.L. Ebos et al. CANCER RESEARCH
- Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients
- (2008) Frank Diehl et al. GASTROENTEROLOGY
- High Detection Rates of Colorectal Neoplasia by Stool DNA Testing With a Novel Digital Melt Curve Assay
- (2008) Hongzhi Zou et al. GASTROENTEROLOGY
- LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
- (2008) Shuji Ogino et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-Throughput Hacking of the Methylation Patterns in Breast Cancer by In vitro Transcription and Thymidine-Specific Cleavage Mass Array on MALDI-TOF Silico-Chip
- (2008) R. Radpour et al. MOLECULAR CANCER RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
- (2008) D. Santini et al. ONCOLOGIST
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started